HJC0152 is primarily utilized in research settings to study its potential as an inhibitor of specific protein-protein interactions, particularly those involving the p53-MDM2 pathway. This pathway is crucial in regulating cell cycle and apoptosis, making HJC0152 a valuable tool in cancer research. Scientists explore its ability to restore p53 function in cancer cells, which could lead to the development of novel therapeutic strategies. Additionally, it is used in biochemical assays to understand the mechanisms of small molecule inhibitors in disrupting oncogenic pathways. Its application extends to preclinical studies aimed at evaluating its efficacy and safety as a potential anticancer agent.